The 24th International Symposium on ALS/MND was the most successful to date with over 950 clinicians, healthcare professionals and scientists attending the meeting in Milan.
There was a ‘hive’ of activity on social media this year with over twenty researchers ‘tweeting’ during the event and fourteen of them reporting on our peer-to-peer blog ReCCoB. We also contributed by tweeting updates throughout the conference using the hashtag #alssymp. You can view the tweets from the symposium here (even if you don’t have a Twitter account!).
With over 100 presentations and nearly 400 posters there was a wealth of clinical and scientific research discussed during the symposium. Networking amongst researchers also stretched out over coffee and lunch breaks, with a number of new international collaborations formed by the end of the meeting. Read More »
The 24th International Symposium on ALS/MND is now only one week away! We’re busy making final preparations and getting ready to report from the event, whilst researchers around the world are packing their suitcases, finishing off their posters and tweaking their presentations.
But, what is it like to attend the symposium? What do researchers gain from attending? One of our grantees, and member of our Biomedical Research Advisory Panel (BRAP), Dr Janine Kirby (Sheffield Institute for Translational Neuroscience) will be attending this year’s event. Dr Kirby has kindly agreed to explain why she attends the symposium and what researchers gain by attending this prestigious event:
“The symposium gives you the opportunity to surround yourself with the latest motor neurone disease research from across the world in one location. From advances in genetics to the latest healthcare research the symposium really does have it all!
It’s not just researchers, clinicians and healthcare professionals who attend the International Symposium on ALS/MND. One of our trustees, Julie Draper, will be attending this year’s symposium after a break of 11 years to find out the latest developments and view the symposium first hand as a trustee.
Here Julie explains a bit about herself and why she’s attending the symposium: